Compare HAYW & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HAYW | TXG |
|---|---|---|
| Founded | 1925 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.6B |
| IPO Year | 2021 | 2019 |
| Metric | HAYW | TXG |
|---|---|---|
| Price | $14.81 | $31.62 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 15 |
| Target Price | $17.50 | ★ $20.25 |
| AVG Volume (30 Days) | 2.1M | ★ 3.0M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.93 | ★ 76.97 |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $1,122,155,000.00 | $245,893,000.00 |
| Revenue This Year | $6.22 | N/A |
| Revenue Next Year | $5.96 | $7.33 |
| P/E Ratio | $132.82 | ★ N/A |
| Revenue Growth | 6.71 | ★ 68.06 |
| 52 Week Low | $12.93 | $10.38 |
| 52 Week High | $17.73 | $35.65 |
| Indicator | HAYW | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 57.98 | 64.46 |
| Support Level | $14.37 | $16.11 |
| Resistance Level | $16.51 | $35.65 |
| Average True Range (ATR) | 0.38 | 2.36 |
| MACD | 0.11 | -0.02 |
| Stochastic Oscillator | 76.45 | 66.00 |
Hayward Holdings is a leading manufacturer of energy-efficient swimming pool equipment and pool automation systems. The company offers a wide range of pool equipment, including pumps, filters, heaters, LED lights, and sanitization. Headquartered in Charlotte, North Carolina, the company has around 2,000 full-time employees. Hayward generated approximately $1.1 billion in revenue in 2025.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).